Hemoperfusion Online Tool TAMU

Patient

Patient name

Patient ID / MRN

Owner

Species

Breed

Age (years)

Sex

Body weight (kg)

Encounter (this HP session)

Identifies this hemoperfusion session — appears at the top-left of both printed sheets.

Date

Time

Clinician

Step 1 — Patient characteristics & indications

PCV / HCT (%)

TS (g/dL)

Blood type

Hydration status

Euhydrated — MM moist with normal skin turgor <5% Dehydrated — MM moist with normal skin turgor 5–6% Dehydrated — MM tacky with mild decreased skin turgor 6–8% Dehydrated — MM dry with decreased skin turgor 8–10% Dehydrated — MM dry, skin tent, retracted globes 10–12% Dehydrated — persistent skin tent, retracted globes, dull corneas, decreased perfusion >12% Dehydrated — persistent skin tent, retracted globes, dull corneas, hypovolemic shock

Indications for HP (check all that apply)

Intoxication Removal of cytokines (sepsis) Severe hyperbilirubinemia

Other indication

Toxin / drug details

Pick a toxin from the curated list (PK fields auto-populate) or choose "Custom" to type values manually. Up to 3 toxins.

HP indication criteria (all must be true): toxicity likely to cause significant organ injury / death · extracorporeal clearance > endogenous clearance · benefits > risks · no antidote available.
HP works regardless of protein binding (IRIS Rec. 3.4); MW window 100 Da – 60 kDa. Vd is the key predictor: prefer ≤1 L/kg (most efficient), 1–2 L/kg acceptable, >2 L/kg suboptimal (per IRIS 2026 Table 7 + Foster 2020). High PB (>80%) is HP's niche over HD.

Other patient characteristics

Check all that apply.

¹ Monitor closely — HP can further reduce these. ² Proceed with extreme caution (HP can drop platelets 30–50%). ³ Relative contraindication for RCA. ⁴ Relative-to-strong contraindication for systemic heparinization. ⁵ Consider ↑ heparin to prevent extracorporeal clotting. ⁶ Risk of refractory hypotension; closer monitoring.

Pre-HP requirements (complete contraindication check)

All criteria below must be met before starting HP. Tool will flag any unmet criterion.

Body weight ≥5–10 kg (if not, prime circuit with WB or pRBC + FFP) Normotensive (SBP >80 and MAP >60 mm Hg) Blood typed and cross-matched compatible blood on hand PCV ≥20% (dog) or ≥18% (cat) ECV ≤15% of patient's BV (calculated below) Non-aggressive temperament for prolonged contact

Step 2 — HP column & circuit

Enter body weight to compute estimated blood volume (BV).

HP column

AimaLojic V100 — 40 mL prime, 15 g toxin capacity (ACV_DUO100) AimaLojic V300 — 165 mL prime, 45 g toxin capacity (ACV_DUO300) VetResQ 50 mL (<20 kg) — 17 mL prime VetResQ 150 mL (20–40 kg) — 47 mL prime VetResQ 300 mL (>40 kg) — 150 mL prime

True toxin capacities are closer to 10 g (V100) and 30 g (V300) — ~⅓ of adsorbent binds non-target circulating particles.

HP tubing / circuit kit

Custom kit for manual HP — 12.6 mL prime AimaLojic Small Tubing Kit (ATKS) — 34 mL prime, max 80 mL/min (ATV_PK0011) AimaLojic Medium Tubing Kit (ATKM) — 97 mL prime, max 350 mL/min (ATV_PK0021) VetResQ X-Small Purify Tubing Kit — 38 mL prime VetResQ Small Purify Tubing Kit — 41 mL prime VetResQ Regular Purify Tubing Kit — 64 mL prime

Other extracorporeal volume (mL)

Choose a column + tubing kit to compute total extracorporeal circuit volume (ECV).

Step 3 — IV access

Distance between catheter insertion site and 4th ICS (cm)

Hemodialysis catheter selection

MILA 7 Fr × 16 cm — Qb 20–50 mL/min (BW <5–7 kg) MILA 8 Fr × 14 cm — Qb 60–80 mL/min (BW <12 kg) MILA 8 Fr × 16 cm — Qb 50–70 mL/min (BW <12 kg) MILA 12 Fr × 16 cm — Qb 50–100 mL/min (BW >12 kg) MILA 12 Fr × 25 cm — Qb 50–100 mL/min (BW >12 kg) Other:

Other catheter

Right jugular preferred over left. Arterial/access fenestration should be in the right atrium. HP typically requires Qb 50–200 mL/min. The AimaLojic Small kit max Qb is 80 mL/min.

Step 4 — Treatment intensity

Day of HP schedule

HP treatment number

Prescribed number of blood volumes (BV) treated

15 × BV 20 × BV 25 × BV Other: × BV

Sources recommend starting with 15–25 BV depending on dose and severity. Continue treatment until clinical signs resolve.

Choose BW + species + BV multiplier to see prescribed total BV.

Step 5 — Estimated duration of HP session

Anticipated blood-flow rate Qb (mL/min)

Enter Qb to estimate session duration and transit times.

Step 6 — Mid-treatment cartridge change

Yes No Base off clinical improvement with therapy

Timing of cartridge change #1 (min into treatment)

Timing of cartridge change #2 (min into treatment)

If clinical signs initially improve then plateau or worsen, this supports cartridge saturation. Carprofen, ibuprofen, phenobarbital, vincristine often need 2+ cartridge changes.

Step 7 — Anticoagulation

Systemic heparinization (target ACT 180–200 sec or aPTT 1.5–2.0× baseline; some sources recommend ACT 200–300 sec for HP — IRIS 2026 Rec. 5.7a) Regional citrate anticoagulation (per device IFU; not recommended for stand-alone HP)

Heparin syringe(s) — pre-machine bolus + CRI

Two heparin syringes are typically prepared. Syringe #1 = pre-machine bolus + CRI. Syringe #2 = loaded into the machine pump for the treatment.

Syringe brand (ReVive HP)

Heparin final concentration (IU/mL)

ReVive HP only accepts 100 / 500 / 1000 / 2000 / 3000 / 5000 IU/mL. PrisMax accepts any concentration.

Pick a final heparin concentration to see dilution instructions (5,000 IU/mL stock).

Heparin bolus dose

Initial UFH bolus (0–50 IU/kg)

IRIS 2026 Rec. 5.7a suggests 50 IU/kg IV (dog) or 25 IU/kg IV (cat) as the initial bolus; adjust based on baseline ACT/PTT.

Enter BW and bolus dose to see the bolus volume.

Heparin CRI rate

Initial UFH CRI rate (10–50 IU/kg/hr)

Enter BW + CRI rate to see mL/hr.

Machine setup

AimaLojic ReVive HP VetResQ PuriFi Other / manual

Sterile priming protocol

Volume priming (mL) — PuriFi only

PuriFi treatment type

PuriFi treatment time (HH:MM)

Setup notes / other

Pre- and post-treatment snapshot (for HP Worksheet Summary)

These two columns drive the top half of the printed Summary sheet.

Parameter	Immediately pre-treatment	Immediately post-treatment
Date / Time
Body weight (kg)
Hydration status (% over/under)
UOP (mL/kg/hr; check one)	Normal Oliguria Anuria Polyuria	N/A
Mentation	BAR QAR Obtunded	BAR QAR Obtunded
Rectal temperature type °F or °C — the other auto-fills	°F °C	°F °C
Heart rate (bpm)
Respiratory rate (rpm) & effort
MM color & CRT (sec)	Pink Pale	Pink Pale
Other significant PE findings
Systolic blood pressure (mm Hg)
PCV (%) / TS (g/dL)
Blood glucose type mg/dL or mmol/L — the other auto-fills	mg/dL mmol/L	mg/dL mmol/L
Patient venous iCa²⁺ (mmol/L)
ACT or aPTT (sec)
Total blood volume treated (mL)	N/A

Indication for HP (free text)

Contraindications / other concerns (free text)

Plan preview

Fill in the form above to see a live plan summary here.

Hemoperfusion (HP) Worksheet Tool

Patient

Encounter (this HP session)

Step 1 — Patient characteristics & indications

Hydration status

Indications for HP (check all that apply)

Toxin / drug details

Other patient characteristics

Pre-HP requirements (complete contraindication check)

Step 2 — HP column & circuit

HP column

HP tubing / circuit kit

Step 3 — IV access

Hemodialysis catheter selection

Step 4 — Treatment intensity

Prescribed number of blood volumes (BV) treated

Step 5 — Estimated duration of HP session

Step 6 — Mid-treatment cartridge change

Step 7 — Anticoagulation

Heparin syringe(s) — pre-machine bolus + CRI

Heparin bolus dose

Heparin CRI rate

Machine setup

Pre- and post-treatment snapshot (for HP Worksheet Summary)

Plan preview

Join Our Free Trial

📁 Saved cases & backup

Patient

Encounter (this HP session)

Step 1 — Patient characteristics & indications

Hydration status

Indications for HP (check all that apply)

Toxin / drug details

Other patient characteristics

Pre-HP requirements (complete contraindication check)

Step 2 — HP column & circuit

HP column

HP tubing / circuit kit

Step 3 — IV access

Hemodialysis catheter selection

Step 4 — Treatment intensity

Prescribed number of blood volumes (BV) treated

Step 5 — Estimated duration of HP session

Step 6 — Mid-treatment cartridge change

Step 7 — Anticoagulation

Heparin syringe(s) — pre-machine bolus + CRI

Heparin bolus dose

Heparin CRI rate

Machine setup

Pre- and post-treatment snapshot (for HP Worksheet Summary)

Plan preview

Join Our Free Trial